Role of the Tumor Microenvironment in Breast Cancer

Pathobiology - Tập 82 Số 3-4 - Trang 142-152 - 2015
Savas D. Soysal1, Alexandar Tzankov, Simone Muenst
1Department of Surgery, University Hospital Basel, Basel, Switzerland

Tóm tắt

In recent years, it has been shown that breast cancer consists not only of neoplastic cells, but also of significant alterations in the surrounding stroma or tumor microenvironment. These alterations are now recognized as a critical element for breast cancer development and progression, as well as potential therapeutic targets. Various components of the breast cancer microenvironment, such as suppressive immune cells, soluble factors and altered extracellular matrix, act together to impede effective antitumor immunity and promote breast cancer progression and metastasis. Stromal cells in the breast cancer microenvironment are characterized by molecular alterations and aberrant signaling pathways, some of which are prognostic of clinical outcome. Several new therapies targeting stromal components are in development or undergoing clinical trials. We focus herein on the composition of the breast cancer microenvironment and concomitant molecular alterations, the specific interplay between various cell types and cancer cells, and the clinical implications of these findings.

Từ khóa


Tài liệu tham khảo

10.1038/ng1596

10.1038/nm1764

10.1016/j.breast.2013.07.010

10.1042/BSR20130060

10.1016/j.gde.2007.12.006

10.1016/j.ccr.2008.03.007

10.1007/s10911-005-9585-5

10.1056/NEJM198612253152606

10.1016/j.mce.2013.06.003

10.2147/OTT.S36109

10.1016/j.semcancer.2003.10.003

10.1038/ncomms2766

10.1186/1471-2407-14-49

10.1002/cncr.11132

10.1186/bcr2912

10.1073/pnas.1016234107

10.1038/nature09707

10.1016/j.cell.2009.11.025

10.1016/j.ccr.2004.06.010

10.1186/bcr2222

10.1038/ng.117

10.1158/0008-5472.CAN-05-2508

10.1158/0008-5472.CAN-04-1708

10.1038/nm.1908

10.1002/path.2803

10.1590/S1415-47572014000400002

10.1016/j.cell.2005.02.034

10.1016/j.semcancer.2014.01.005

10.1158/0008-5472.CAN-05-3202

10.1038/nrc1877

10.1007/s11154-007-9037-1

10.1002/ijc.10750

10.1186/bcr1775

10.4161/cbt.8.11.8874

10.2353/ajpath.2009.080924

10.1002/ijc.28848

10.5306/wjco.v5.i3.495

10.1146/annurev.immunol.21.120601.141040

10.1096/fj.09-147025

10.1097/00000658-199707000-00001

10.1172/JCI57099

10.4049/jimmunol.0803926

10.1016/j.immuni.2008.08.004

10.1038/nature07205

10.1189/jlb.0609385

10.1161/ATVBAHA.113.300168

10.1038/nrc2618

10.3892/or.14.2.425

10.1371/journal.pone.0076147

10.1200/JCO.2010.30.5037

10.1038/modpathol.2008.160

10.1007/s00262-008-0570-x

10.1385/IR:32:1-3:155

10.1631/jzus.B1300264

10.1126/science.1203486

10.1016/j.cell.2011.02.013

10.1517/14728222.2014.980235

10.1016/j.clim.2014.04.010

10.1007/s10549-014-2988-5

10.1007/s10549-013-2581-3

10.1038/jid.2011.30

10.1038/nm730

10.1007/s00262-004-0593-x

10.2147/BCTT.S46020

10.1083/jcb.201102147

10.2353/ajpath.2006.051321

10.1002/ijc.10329

10.1016/j.cell.2009.10.027

10.1038/nature04695

10.1073/pnas.1017360108

10.1097/CCO.0000000000000122

10.1016/j.cellsig.2014.07.034

10.1056/NEJMoa072113

10.1001/jama.2011.51

10.1016/j.ccr.2009.01.021

10.1158/1078-0432.CCR-04-0730

10.1084/jem.20080108

10.1016/j.ccr.2010.11.009

10.1158/2159-8274.CD-10-0028

10.1093/annonc/mdu134

10.1002/eji.201242505

10.1158/0008-5472.CAN-04-1844

10.1016/j.bmcl.2012.10.138

10.1200/JCO.2009.26.7609

10.1056/NEJMoa1200694

10.1056/NEJMoa1200690

10.1016/S1470-2045(15)70208-1

10.1016/j.coi.2008.04.008

10.1371/journal.pone.0005620

10.1007/s10549-012-1986-8

10.1186/bcr2769

10.1016/j.canlet.2014.05.006

10.1371/journal.pone.0085398

10.2147/OTT.S70654

10.1007/s00280-014-2628-0

10.1007/s13277-014-2799-7

10.1158/0008-5472.CAN-08-0294

10.1186/1479-5876-9-178

10.1007/s00262-011-1192-2

10.1126/scitranslmed.3003330

10.3892/ol.2014.1982

10.1016/j.ygyno.2005.05.023